Hsieh Sidney H-K, Ferraro Gino B, Fournier Alyson E
Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec, H3A 2B4, Canada.
J Neurosci. 2006 Jan 18;26(3):1006-15. doi: 10.1523/JNEUROSCI.2806-05.2006.
Myelin-associated inhibitors (MAIs) signal through a tripartate receptor complex on neurons to limit axon regeneration in the CNS. Inhibitory influences ultimately converge on the cytoskeleton to mediate growth cone collapse and neurite outgrowth inhibition. Rho GTPase and its downstream effector Rho kinase are key signaling intermediates in response to MAIs; however, the links between Rho and the actin cytoskeleton have not been fully defined. We found that Nogo-66, a potent inhibitory fragment of Nogo-A, signals through LIM (LIM is an acronym of the three gene products Lin-11, Isl-1, and Mec-3) kinase and Slingshot (SSH) phosphatase to regulate the phosphorylation profile of the actin depolymerization factor cofilin. Blockade of LIMK1 activation and subsequent cofilin phosphorylation circumvents myelin-dependent inhibition in chick dorsal root ganglion neurons, suggesting that phosphorylation and inactivation of cofilin is critical for neuronal inhibitory responses. Subsequent activation of SSH1 phosphatase mediates cofilin dephosphorylation and reactivation. Overexpression of SSH1 does not mimic the neurite outgrowth inhibitory effects of myelin, suggesting an alternative role in MAI inhibition. We speculate that SSH-mediated persistent cofilin activation may be responsible for maintaining an inhibited neuronal phenotype in response to myelin inhibitors.
髓磷脂相关抑制剂(MAIs)通过神经元上的三方受体复合物发出信号,以限制中枢神经系统(CNS)中的轴突再生。抑制性影响最终汇聚于细胞骨架,以介导生长锥塌陷和神经突生长抑制。Rho GTP酶及其下游效应物Rho激酶是响应MAIs的关键信号中间体;然而,Rho与肌动蛋白细胞骨架之间的联系尚未完全明确。我们发现,Nogo-66(Nogo-A的一种强效抑制性片段)通过LIM(LIM是三个基因产物Lin-11、Isl-1和Mec-3的首字母缩写)激酶和弹弓(SSH)磷酸酶发出信号,以调节肌动蛋白解聚因子丝切蛋白的磷酸化状态。阻断LIMK1激活及随后的丝切蛋白磷酸化可规避鸡背根神经节神经元中髓磷脂依赖性抑制,这表明丝切蛋白的磷酸化和失活对于神经元抑制反应至关重要。随后SSH1磷酸酶的激活介导丝切蛋白去磷酸化并使其重新激活。SSH1的过表达并不会模拟髓磷脂的神经突生长抑制作用,提示其在MAI抑制中具有其他作用。我们推测,SSH介导的丝切蛋白持续激活可能负责维持神经元对髓磷脂抑制剂产生的抑制表型。